Cargando…

Increase in ticagrelor use over time is associated with lower rates of ischemic stroke following myocardial infarction

OBJECTIVES: To evaluate the impact of a rapid change in preferred treatment from clopidogrel to ticagrelor on the risk of ischemic stroke following acute myocardial infarction (AMI). METHODS: Data for AMI patients treated with either clopidogrel or ticagrelor were obtained from the Swedish Register...

Descripción completa

Detalles Bibliográficos
Autores principales:	Henriksson, Robin, Ulvenstam, Anders, Söderström, Lars, Mooe, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6399852/ https://www.ncbi.nlm.nih.gov/pubmed/30832574 http://dx.doi.org/10.1186/s12872-019-1030-6

Ejemplares similares

The introduction of ticagrelor is associated with lower rates of recurrent ischemic stroke after myocardial infarction
por: Henriksson, Robin, et al.
Publicado: (2019)

Risk of Ischemic Stroke After Acute Myocardial Infarction in Patients Undergoing Coronary Artery Bypass Graft Surgery
por: Åström, André, et al.
Publicado: (2020)

Incidence and predictors of serious bleeding during long-term follow-up after acute coronary syndrome in a population-based cohort study
por: Graipe, Anna, et al.
Publicado: (2021)

Incidence and predictors of cardiovascular outcomes after acute coronary syndrome in a population-based cohort study
por: Ulvenstam, Anders, et al.
Publicado: (2023)

Long-term risk of major adverse cardiovascular events following ischemic stroke or TIA
por: Carlsson, Andreas, et al.
Publicado: (2023)

Serious hemorrhages after ischemic stroke or TIA – Incidence, mortality, and predictors
por: Ögren, Joachim, et al.
Publicado: (2018)

Pre-hospital delay in patients with first time myocardial infarction: an observational study in a northern Swedish population
por: Nilsson, Gunnar, et al.
Publicado: (2016)

Incidence, Time Trends, and Predictors of Intracranial Hemorrhage During Long‐Term Follow‐up After Acute Myocardial Infarction
por: Graipe, Anna, et al.
Publicado: (2015)

Effects of Ticagrelor on Myocardial Infarct Size
por: Hahn, Joo-Yong
Publicado: (2017)

Implementation of Telephone-Based Secondary Preventive Intervention after Stroke and Transient Ischemic Attack – Participation Rate, Reasons for Nonparticipation and One-Year Mortality
por: Irewall, Anna-Lotta, et al.
Publicado: (2014)

Statin treatment after acute coronary syndrome: Adherence and reasons for non-adherence in a randomized controlled intervention trial
por: Daniel, Huber, et al.
Publicado: (2019)

Author Correction: Statin treatment after acute coronary syndrome: Adherence and reasons for non-adherence in a randomized controlled intervention trial
por: Huber, Daniel, et al.
Publicado: (2021)

Will Ticagrelor Help Post-Myocardial Infarction ‘Healing’?
por: Park, Kyung Woo
Publicado: (2019)

Ticagrelor Resistance in Cardiovascular Disease and Ischemic Stroke
por: He, Song, et al.
Publicado: (2023)

Ticagrelor versus clopidogrel in the management of acute myocardial infarction
por: Volney, Candice, et al.
Publicado: (2019)

Effects of ticagrelor in a mouse model of ischemic stroke
por: Yamauchi, Keita, et al.
Publicado: (2017)

Ticagrelor Added to Aspirin in Acute Nonsevere Ischemic Stroke or Transient Ischemic Attack of Atherosclerotic Origin
por: Amarenco, Pierre, et al.
Publicado: (2020)

Ticagrelor-Induced Torsades de Pointes following Myocardial Infarction
por: Bu, Seong Hyeon, et al.
Publicado: (2022)

Nurse-Led, Telephone-Based, Secondary Preventive Follow-Up after Stroke or Transient Ischemic Attack Improves Blood Pressure and LDL Cholesterol: Results from the First 12 Months of the Randomized, Controlled NAILED Stroke Risk Factor Trial
por: Irewall, Anna-Lotta, et al.
Publicado: (2015)

Time Course for Benefit and Risk of Ticagrelor and Aspirin in Acute Ischemic Stroke or Transient Ischemic Attack
por: Wang, Yongjun, et al.
Publicado: (2022)

Long-term, telephone-based follow-up after stroke and TIA improves risk factors: 36-month results from the randomized controlled NAILED stroke risk factor trial
por: Ögren, Joachim, et al.
Publicado: (2018)

Nurse-based secondary preventive follow-up by telephone reduced recurrence of cardiovascular events: a randomised controlled trial
por: Irewall, Anna-Lotta, et al.
Publicado: (2021)

Ticagrelor Added to Aspirin in Acute Ischemic Stroke or Transient Ischemic Attack in Prevention of Disabling Stroke: A Randomized Clinical Trial
por: Amarenco, Pierre, et al.
Publicado: (2020)

Reduction in Subtypes and Sizes of Myocardial Infarction With Ticagrelor in PEGASUS–TIMI 54
por: Bonaca, Marc P., et al.
Publicado: (2018)

Effects of Ticagrelor and Clopidogrel on Coronary Microcirculation in Patients with Acute Myocardial Infarction
por: Scanavini-Filho, Marco Antonio, et al.
Publicado: (2022)

Ticagrelor versus clopidogrel for recurrent myocardial infarction: An outcomes-based agreement
por: Peasah, Samuel K., et al.
Publicado: (2023)

Ischemic Benefit and Hemorrhage Risk of Ticagrelor-Aspirin Versus Aspirin in Patients With Acute Ischemic Stroke or Transient Ischemic Attack
por: Johnston, S. Claiborne, et al.
Publicado: (2021)

Ticagrelor attenuates the increase of extracellular vesicle concentrations in plasma after acute myocardial infarction compared to clopidogrel
por: Gasecka, Aleksandra, et al.
Publicado: (2020)

Implementation of Ticagrelor Reduced Mortality in Routine Clinical Care: Evidence From a Natural Experiment Including 109 995 Patients With Myocardial Infarction in Sweden
por: Johannesen, Kasper, et al.
Publicado: (2023)

Diurnal Variability of Platelet Aggregation in Patients with Myocardial Infarction Treated with Prasugrel and Ticagrelor
por: Adamski, Piotr, et al.
Publicado: (2022)

Low platelet reactivity in patients with myocardial infarction treated with aspirin plus ticagrelor
por: Costa, Thiago Guarato Rodrigues, et al.
Publicado: (2022)

Comparison between ticagrelor and clopidogrel in myocardial infarction patients with high bleeding risk
por: Tjerkaski, Jonathan, et al.
Publicado: (2023)

Remote Ischemic Conditioning in Ischemic Stroke and Myocardial Infarction: Similarities and Differences
por: Saccaro, Luigi F., et al.
Publicado: (2021)

The Acute Stroke or Transient Ischemic Attack Treated with Ticagrelor and Aspirin for Prevention of Stroke and Death (THALES) trial: Rationale and design
por: Johnston, S Claiborne, et al.
Publicado: (2019)

Advantages of DES over BMS in Preventing the Risk of Myocardial Infarction, Ischemic Stroke, and Mortality in Various Populations
por: Wu, Pei-Ning, et al.
Publicado: (2022)

Ticagrelor Use in Acute Myocardial Infarction: Insights From the National Cardiovascular Data Registry
por: Basra, Sukhdeep S., et al.
Publicado: (2018)

Ticagrelor Can Be an Important Agent in the Treatment of Severe COVID-19 Patients with Myocardial Infarction
por: Akşit, Ercan, et al.
Publicado: (2020)

Safety and feasibility of low‐dose ticagrelor in patients with ST‐segment elevation myocardial infarction
por: Wang, Yanbo, et al.
Publicado: (2020)

Differential modulation of polyunsaturated fatty acids in patients with myocardial infarction treated with ticagrelor or clopidogrel
por: Samman, Karla N., et al.
Publicado: (2021)

Pharmacokinetic–pharmacodynamic modelling of platelet response to ticagrelor in stable coronary artery disease and prior myocardial infarction patients
por: Åstrand, Magnus, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_3i5rrm87vp33i2s7nt9fdi08dv